ChemicalBook > Product Catalog >API >Digestive system drugs >Antacid and Mucosal protective Drugs >Pantoprazole

Pantoprazole

Pantoprazole Structure
CAS No.
102625-70-7
Chemical Name:
Pantoprazole
Synonyms
BY-1023;SKF-96022;Patoprazole;PANTOPRAZOLE;Pantoprozole;Pantoprazole D7;Pantoprazole&Int.;Pantoprazole Acid;Pantoprazole (BY1023);Pantoprazole USP/EP/BP
CBNumber:
CB8129842
Molecular Formula:
C16H15F2N3O4S
Molecular Weight:
383.37
MOL File:
102625-70-7.mol
MSDS File:
SDS
Modify Date:
2024/3/16 7:03:48

Pantoprazole Properties

Melting point 139-140° (dec)
Boiling point 586.9±60.0 °C(Predicted)
Density 1.51±0.1 g/cm3(Predicted)
storage temp. Inert atmosphere,Store in freezer, under -20°C
solubility Chloroform (Slightly), Methanol (Slightly, Heated, Sonicated)
pka pKa1 3.92; pKa2 8.19(at 25℃)
form Solid
color Off-White to Pale Orange
BCS Class 3
InChI InChI=1S/C16H15F2N3O4S/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16/h3-7,15H,8H2,1-2H3,(H,20,21)
InChIKey IQPSEEYGBUAQFF-UHFFFAOYSA-N
SMILES C1(S(CC2=NC=CC(OC)=C2OC)=O)NC2=CC(OC(F)F)=CC=C2N=1
CAS DataBase Reference 102625-70-7(CAS DataBase Reference)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302+H312+H332
Hazard Codes  Xn
Risk Statements  20/21/22-37/38-41-48
Safety Statements  22-26-36/37/39-45
NFPA 704
0
3 0

Pantoprazole Chemical Properties,Uses,Production

Description

Pantoprazole, an irreversible proton pump inhibitor, reached its first market worldwide in Germany for acute treatment of gastric and duodenal ulcers and gastroesophageal reflux disease. Proton pump inhibitors are more effective than other strategies in inhibiting acid secretion since they function at the final step of acid production, therefore, provide superior symptom relief and healing in all acid related diseases. As the third substituted benzimidazole proton pump inhibitor marketed, pantoprazole not only has superior ulcer-preventing effect but also is more potent than omeprazole in healing acetic acid-induced gastric and duodenal ulcers with extremely low acute toxicity. The mechanism of action for this class of compounds has been suggested to be mediated via the protonated form of the molecule which selectively reacts with cysteines present on the extracytoplasmic face of the enzyme to form covalent disulfide bonds.

Uses

proton pump inhibitor, gastric acid release inhibitor, antiulcer

Definition

ChEBI: A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Global( 249)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Jigs Chemical ltd +919099003427 Gujarat, India 239 58 Inquiry
ANWITA APIS +919000311012 Hyderabad, India 198 58 Inquiry
KARPSCHEM LABORATORIES +91-7249203006 +91-7249203006 Maharashtra, India 786 58 Inquiry
Metrochem API Private Limited +91-4069069999 +91-4069069999 Telangana, India 78 58 Inquiry
Dodhia Group +91-9619867345 +91-9619867345 Mumbai, India 129 58 Inquiry
Sainor Life Sciences Pvt Ltd +919542990009 AndhraPradesh, India 13 58 Inquiry
Prachi Pharmaceuticals Pvt Ltd +919004877711 Mumbai, India 36 58 Inquiry
Macleods Pharmaceuticals Limited +91-2266762800 +91-2266762800 Maharashtra, India 116 58 Inquiry
Lakshmi Farmachem +91-9948795885 +91-9550886476 Telangana, India 407 58 Inquiry
Ralington Pharma +91-7948911722 +91-9687771722 Gujarat, India 1350 58 Inquiry

Pantoprazole Spectrum

5-(DIFLUOROMETHOXY)-2-[[(3,4-DIMETHOXY-2-PYRIDINYL)METHYL]SULFINYL]-1H-BENZIMIDAZOLE 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1h-benzimidazole PANTOPRAZOLE PANTOPRAZOLE SODIUM 98-102% Pantoprazole (base and/or unspecified salts) Pantoprazole&Int. 5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-3H-benzoimidazole (3,4-dimethoxy-2-pyridinyl)methyl 5-methyl-1H-1,3-benzimidazol-2-yl sulfoxide 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyriainyl)methyl]sulfinyl]-1H-benzimidazole BY-1023 SKF-96022 [(3,4-Dimethoxypyridin-2-yl)methyl][5-(difluoromethoxy)-1H-benzimidazol-2-yl] sulfoxide 5-(Difluoromethoxy)-1H-benzimidazole-2-yl(3,4-dimethoxy-2-pyridylmethyl) sulfoxide Pantoprazole (Protonix) Patoprazole 5-(difluoMethoxyl)-2-{[(3,4-diMethoxyl-2-pyridy 1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]- 6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridinyl)methylsulfinyl]-1H-benzimidazole Pantoprazole Acid Pantoprazole USP/EP/BP Pantoprozole Pantoprazole (BY1023) Pantoprazole for System suitability (Y0001001) Pantoprazole D7 TIANFU-CHEM Pantoprazole 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-yridinyl)methyl]sulfinyl]-1h-benzimidazole Benzenemethanol,3-bromo-6-ethyl- PANTOPRAZOLE 8.5%, 14% , 15%, 22% PELLETS Pantoprazole 5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2- yl)methyl)sulfinyl)-1H-benzo[d]imidazole Pantoprazole EC Pellets 5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole 102625-70-7 C16H12F2N3O4SD3 C16H15N3O4F2S C16H15F2N3O4S Isotopically Labeled Pharmaceutical Reference Standard PROTONIX ACTIVE PHARMACEUTICAL INGREDIENTS Metabolite Reference Standard APIs Pantoprazole API's